The ROE as of December 2025 (TTM) for Modus Therapeutics Holding AB (publ) (MODTX.ST) is -774.44%

According to Modus Therapeutics Holding AB (publ)’s latest financial reports and current stock price. The company's current ROE is -774.44%. This represents a change of -1315.99% compared to the average of 63.69% of the last 4 quarters.

Modus Therapeutics Holding AB (publ) (MODTX.ST) Historical ROE (quarterly & annually)

How has MODTX.ST ROE performed in the past?

The mean historical ROE of Modus Therapeutics Holding AB (publ) over the last ten years is 153.88%. The current -774.44% ROE has changed -603.29% with respect to the historical average. Over the past ten years (40 quarters), MODTX.ST's ROE was at its highest in in the March 2025 quarter at 415.19%. The ROE was at its lowest in in the December 2024 quarter at -220.54%.

Modus Therapeutics Holding AB (publ) (MODTX.ST) ROE by Quarter and Year

Discovering the peaks and valleys of Modus Therapeutics Holding AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Modus Therapeutics Holding AB (publ) (MODTX.ST) Average ROE

How has MODTX.ST ROE performed in the past?

The current ROE of Modus Therapeutics Holding AB (publ) (MODTX.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Modus Therapeutics Holding AB (publ) (MODTX.ST) ROE vs. Peers

How is MODTX.ST’s ROE compared to its peers?

Modus Therapeutics Holding AB (publ)’s ROE is greater than ExpreS2ion Biotech Holding AB (publ) (-95.18%), greater than 2cureX AB (publ) (-48.06%), less than Aino Health AB (publ) (413.35%), greater than Guard Therapeutics International AB (publ) (-204.93%), greater than Episurf Medical AB (publ) (-95.80%), greater than Stayble Therapeutics AB (publ) (-103.16%), less than Simris Alg AB (publ) (670.62%), greater than Fluicell AB (publ) (-45.98%), less than Qlife Holding AB (publ) (800.38%), greater than Lipigon Pharmaceuticals AB (publ) (-192.99%),

Build a custom stock screener for Modus Therapeutics Holding AB (publ) (MODTX.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Modus Therapeutics Holding AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Modus Therapeutics Holding AB (publ) (MODTX.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Modus Therapeutics Holding AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.